• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
ADO
Click for more information
0.00% 2.1¢

ANTEOTECH LTD - Announcements

Market Cap $54.77M  ! watchlist Created with Sketch. Add to my watchlist

AnteoTech Limited is an Australia-based company engaged in providing solutions for the... AnteoTech Limited is an Australia-based company engaged in providing solutions for the clean energy and life sciences markets using applied materials technology. The principal activities of the Company consist of development and commercialization of nanotechnologies with surface management applications. The Company’s lead product, Anteo X, provides significant improvement in anode performance and the Company partners with global suppliers in lithium-ion battery manufacturing. Its clean energy technology (CET) technologies improve the energy densities, cycle life and cost- effectiveness of lithium-ion batteries. The Company has two programs underway: Anteo X, its binder additive and the High Silicon Anode technology. The Life Sciences division services the point-of-care and in vitro diagnostics markets from global diagnostics companies to technology developers. Its AnteoBind provides advantages in bioconjugation to rapidly speed up testing procedures and improve accuracy.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Claim your IR profile arrow Created with Sketch.
See benefits

Announcements


Plus500
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW
TRADE NOW
Plus500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
TRADE NOW

Filter Results
All Price Sensitive Only
search Created with Sketch. Search
search Created with Sketch. Search
ADO Appendix 3B11/08/15
ADO Quarterly Activities ReportPRICE SENSITIVE31/07/15
ADO AACC conference summary and CEO interview28/07/15
ADO Anteo Entends Relationship with Sigma-AldrichPRICE SENSITIVE23/07/15
ADO IMRA and Anteo move into Product Development Phase08/07/15
ADO Boardroom Radio Interview with Dr Geoff Cumming16/06/15
ADO Section 708(A) Notice01/06/15
ADO Appendix 3B28/05/15
ADO Anteo Raises $1M to Advance Energy ProductsPRICE SENSITIVE26/05/15
ADO Investor Presentation20/05/15
ADO New Product Launch06/05/15
ADO Appendix 3B30/04/15
ADO Appendix 4C March 2015 QuarterlyPRICE SENSITIVE30/04/15
ADO Anteo Files New PatentPRICE SENSITIVE21/04/15
ADO Anteo begins InVivo Research Partnership with UQPRICE SENSITIVE14/04/15
ADO Luminex Endorses Anteo's MIx & Go Kit07/04/15
ADO Anteo Signs New Agreement with Global Healthcare Co.PRICE SENSITIVE01/04/15
ADO Cook Medical Feasibility Study Press Release31/03/15
ADO Feasability Study with Cook AustraliaPRICE SENSITIVE25/03/15
ADO EXCLUSIVE DISTRIBUTION PARTNERSHIP WITH VERITAS CORPORATIONPRICE SENSITIVE10/03/15
ADO New Patent FiledPRICE SENSITIVE24/02/15
ADO Interim Financial Report 31 December 201417/02/15
ADO Appendix 4DPRICE SENSITIVE17/02/15
ADO Appendix 3B04/02/15
ADO Appendix 4C - quarterlyPRICE SENSITIVE30/01/15
ADO Appendix 3B07/01/15
ADO Boardroom Radio Interview with Dr Geoff Cumming23/12/14
ADO Anteo and USA based IMRA Enter in AgreementPRICE SENSITIVE22/12/14
ADO Anteo Technologies Introduces New Product To MarketPRICE SENSITIVE19/12/14
ADO Appendix 3Y05/12/14
ADO Appendix 3B05/12/14
ADO Appendix 3Y19/11/14
ADO Appendix 3Y19/11/14
ADO Appendix 3Y19/11/14
ADO Appendix 3Y19/11/14
ADO Appendix 3B19/11/14
ADO Replacement Appendix 3B11/11/14
ADO Appendix 3B11/11/14
ADO Results of 2014 AGM10/11/14
ADO AGM Presentation10/11/14
ADO Appendix 3B06/11/14
ADO Appendix 4C - quarterlyPRICE SENSITIVE31/10/14
ADO Appendix 3B30/10/14
ADO Proxy Form 2014 AGM07/10/14
ADO Notice of Annual General Meeting07/10/14
ADO Appendix 3B05/09/14
ADO Boardroom Radio Interview02/09/14
ADO Feasibility AgreementPRICE SENSITIVE27/08/14
ADO 2014 Annual Report26/08/14
ADO Preliminary Final ReportPRICE SENSITIVE26/08/14
ADO Patent Cooperation Treaty Application FiledPRICE SENSITIVE25/08/14
ADO Anteo appoints USA based VP Scientific Affairs18/08/14
ADO Quarterly Activities Report Appendix 4CPRICE SENSITIVE31/07/14
ADO New Patent ApplicationPRICE SENSITIVE20/06/14
ADO Amended Appendix 3B08/05/14
ADO Appendix 3B08/05/14
ADO Quarterly Activities Report Appendix 4CPRICE SENSITIVE30/04/14
ADO Appendix 3B03/04/14
ADO Appendix 3B28/03/14
ADO Appendix 3Y27/03/14
ADO Appendix 3B21/03/14
ADO Appendix 3B20/03/14
ADO Appendix 3B18/03/14
ADO Appendix 3B11/03/14
ADO ASX Price Query & ResponsePRICE SENSITIVE10/03/14
AAI +S&P DJ Indices Announces March Quarterly Rebalance07/03/14
ADO Appendix 4D Interim Financial ReportPRICE SENSITIVE25/02/14
ADO Quarterly Activities Report Appendix 4CPRICE SENSITIVE30/01/14
ADO Appendix 3B20/12/13
ADO Section 708(A)(5) Notice20/12/13
ADO Appendix 3B17/12/13
ADO Boardroom Radio Interview $5.5 Million Placement17/12/13
ADO Anteo completes a $5.5 million placementPRICE SENSITIVE16/12/13
ADO Trading HaltPRICE SENSITIVE12/12/13
ADO Appendix 3B04/12/13
ADO Boardroom Radio Interview with Dr Geoff Cumming13/11/13
ADO Appendix 3Y08/11/13
ADO Appendix 3Y08/11/13
ADO Anteo and BBI Solutions Sign Heads of TermsPRICE SENSITIVE08/11/13
ADO Appendix 3B08/11/13
ADO Updated CEO Employment Contract07/11/13
ADO Updated 2013 AGM Results04/11/13
ADO Results of 2013 AGM31/10/13
ADO 2013 AGM Presentation31/10/13
ADO Quarterly Activities Report Appendix 4CPRICE SENSITIVE30/10/13
ADO Australian Microcap Investment Conference Presentation22/10/13
ADO ADO Releases New Mix&Go Based Products for Beta Test21/10/13
ADO Proxy Form 2013 Annual General Meeting02/10/13
ADO Notice of Annual General Meeting02/10/13
ADO Amended Appendix 3B26/08/13
ADO Anteo Files Patent ApplicationsPRICE SENSITIVE26/08/13
ADO Annual Report to shareholders20/08/13
ADO Preliminary Final ReportPRICE SENSITIVE20/08/13
ADO Quarterly Activities Report Appendix 4CPRICE SENSITIVE29/07/13
ADO Board Room Radio Webcast Commercialisation Grant09/07/13
ADO Anteo awarded $1.7M Early Stage Commercialisation GrantPRICE SENSITIVE01/07/13
ADO European Patent UpdatePRICE SENSITIVE24/06/13
ADO Anteo Enters into Feasibility AgreementPRICE SENSITIVE19/06/13
ADO Anteo Partners with GennovaPRICE SENSITIVE22/05/13
ADO Quarterly Activities Report / Appendix 4CPRICE SENSITIVE30/04/13
ADO Appendix 3B
11/08/15
ADO Quarterly Activities Report
31/07/15PRICE SENSITIVE
ADO AACC conference summary and CEO interview
28/07/15
ADO Anteo Entends Relationship with Sigma-Aldrich
23/07/15PRICE SENSITIVE
ADO IMRA and Anteo move into Product Development Phase
08/07/15
ADO Boardroom Radio Interview with Dr Geoff Cumming
16/06/15
ADO Section 708(A) Notice
01/06/15
ADO Appendix 3B
28/05/15
ADO Anteo Raises $1M to Advance Energy Products
26/05/15PRICE SENSITIVE
ADO Investor Presentation
20/05/15
ADO New Product Launch
06/05/15
ADO Appendix 3B
30/04/15
ADO Appendix 4C March 2015 Quarterly
30/04/15PRICE SENSITIVE
ADO Anteo Files New Patent
21/04/15PRICE SENSITIVE
ADO Anteo begins InVivo Research Partnership with UQ
14/04/15PRICE SENSITIVE
ADO Luminex Endorses Anteo's MIx & Go Kit
07/04/15
ADO Anteo Signs New Agreement with Global Healthcare Co.
01/04/15PRICE SENSITIVE
ADO Cook Medical Feasibility Study Press Release
31/03/15
ADO Feasability Study with Cook Australia
25/03/15PRICE SENSITIVE
ADO EXCLUSIVE DISTRIBUTION PARTNERSHIP WITH VERITAS CORPORATION
10/03/15PRICE SENSITIVE
ADO New Patent Filed
24/02/15PRICE SENSITIVE
ADO Interim Financial Report 31 December 2014
17/02/15
ADO Appendix 4D
17/02/15PRICE SENSITIVE
ADO Appendix 3B
04/02/15
ADO Appendix 4C - quarterly
30/01/15PRICE SENSITIVE
ADO Appendix 3B
07/01/15
ADO Boardroom Radio Interview with Dr Geoff Cumming
23/12/14
ADO Anteo and USA based IMRA Enter in Agreement
22/12/14PRICE SENSITIVE
ADO Anteo Technologies Introduces New Product To Market
19/12/14PRICE SENSITIVE
ADO Appendix 3Y
05/12/14
ADO Appendix 3B
05/12/14
ADO Appendix 3Y
19/11/14
ADO Appendix 3Y
19/11/14
ADO Appendix 3Y
19/11/14
ADO Appendix 3Y
19/11/14
ADO Appendix 3B
19/11/14
ADO Replacement Appendix 3B
11/11/14
ADO Appendix 3B
11/11/14
ADO Results of 2014 AGM
10/11/14
ADO AGM Presentation
10/11/14
ADO Appendix 3B
06/11/14
ADO Appendix 4C - quarterly
31/10/14PRICE SENSITIVE
ADO Appendix 3B
30/10/14
ADO Proxy Form 2014 AGM
07/10/14
ADO Notice of Annual General Meeting
07/10/14
ADO Appendix 3B
05/09/14
ADO Boardroom Radio Interview
02/09/14
ADO Feasibility Agreement
27/08/14PRICE SENSITIVE
ADO 2014 Annual Report
26/08/14
ADO Preliminary Final Report
26/08/14PRICE SENSITIVE
ADO Patent Cooperation Treaty Application Filed
25/08/14PRICE SENSITIVE
ADO Anteo appoints USA based VP Scientific Affairs
18/08/14
ADO Quarterly Activities Report Appendix 4C
31/07/14PRICE SENSITIVE
ADO New Patent Application
20/06/14PRICE SENSITIVE
ADO Amended Appendix 3B
08/05/14
ADO Appendix 3B
08/05/14
ADO Quarterly Activities Report Appendix 4C
30/04/14PRICE SENSITIVE
ADO Appendix 3B
03/04/14
ADO Appendix 3B
28/03/14
ADO Appendix 3Y
27/03/14
ADO Appendix 3B
21/03/14
ADO Appendix 3B
20/03/14
ADO Appendix 3B
18/03/14
ADO Appendix 3B
11/03/14
ADO ASX Price Query & Response
10/03/14PRICE SENSITIVE
AAI +S&P DJ Indices Announces March Quarterly Rebalance
07/03/14
ADO Appendix 4D Interim Financial Report
25/02/14PRICE SENSITIVE
ADO Quarterly Activities Report Appendix 4C
30/01/14PRICE SENSITIVE
ADO Appendix 3B
20/12/13
ADO Section 708(A)(5) Notice
20/12/13
ADO Appendix 3B
17/12/13
ADO Boardroom Radio Interview $5.5 Million Placement
17/12/13
ADO Anteo completes a $5.5 million placement
16/12/13PRICE SENSITIVE
ADO Trading Halt
12/12/13PRICE SENSITIVE
ADO Appendix 3B
04/12/13
ADO Boardroom Radio Interview with Dr Geoff Cumming
13/11/13
ADO Appendix 3Y
08/11/13
ADO Appendix 3Y
08/11/13
ADO Anteo and BBI Solutions Sign Heads of Terms
08/11/13PRICE SENSITIVE
ADO Appendix 3B
08/11/13
ADO Updated CEO Employment Contract
07/11/13
ADO Updated 2013 AGM Results
04/11/13
ADO Results of 2013 AGM
31/10/13
ADO 2013 AGM Presentation
31/10/13
ADO Quarterly Activities Report Appendix 4C
30/10/13PRICE SENSITIVE
ADO Australian Microcap Investment Conference Presentation
22/10/13
ADO ADO Releases New Mix&Go Based Products for Beta Test
21/10/13
ADO Proxy Form 2013 Annual General Meeting
02/10/13
ADO Notice of Annual General Meeting
02/10/13
ADO Amended Appendix 3B
26/08/13
ADO Anteo Files Patent Applications
26/08/13PRICE SENSITIVE
ADO Annual Report to shareholders
20/08/13
ADO Preliminary Final Report
20/08/13PRICE SENSITIVE
ADO Quarterly Activities Report Appendix 4C
29/07/13PRICE SENSITIVE
ADO Board Room Radio Webcast Commercialisation Grant
09/07/13
ADO Anteo awarded $1.7M Early Stage Commercialisation Grant
01/07/13PRICE SENSITIVE
ADO European Patent Update
24/06/13PRICE SENSITIVE
ADO Anteo Enters into Feasibility Agreement
19/06/13PRICE SENSITIVE
ADO Anteo Partners with Gennova
22/05/13PRICE SENSITIVE
ADO Quarterly Activities Report / Appendix 4C
30/04/13PRICE SENSITIVE
refresh Created with Sketch. REFRESH
 
(20min delay)
Last
2.1¢ 		Change
0.000(0.00%) 		Mkt cap ! $54.77M
Open High Low Value Volume
2.1¢ 2.2¢ 2.1¢ $6.966K 328.9K

Buyers (Bids)

No. Vol. Price($)
1 235436 2.1¢
 

Sellers (Offers)

Price($) Vol. No.
2.2¢ 642018 2
View Market Depth
Last trade - 15.43pm 30/09/2024 (20 minute delay) ?
Last
2.1¢ 		  Change
0.000 ( 0.00 %)
Open High Low Volume
2.2¢ 2.2¢ 2.1¢ 216911
Last updated 15.32pm 30/09/2024 ?
ADO (ASX) Chart

Top Stories

Actinogen Medical ramps up Alzheimer’s treatment trials, targeting fast-track global approvals

Actinogen Medical is developing a promising oral treatment for Alzheimer's and depression and is accelerating clinical trials with new capital.
The iron ore comeback: Can it last? The Chinese need our iron ore and we could do with the cash if we are sensible enough to put the stuff on a boat and sell it to them.
Zenith's sale of Develin Creek delivers $975K cash, with shares up 13% Zenith Minerals Ltd has completed its sale of Develin Creek copper-zinc project in Queensland to QMines Ltd
Hastings progressing Yangibana to production with lower costs Hastings Technology Metals Ltd has released its annual report to shareholders, saying that it has reduced capital costs by $56 million
Coda Minerals (ASX:COD) enters rights issue to further exploration in South Australia Coda Minerals (ASX:COD) CEO, Chris Stevens, joins The Market Online to discuss the company's current rights issue, and how the capital from this raise will be used to further its copper exploration in South Australia. In addition, Chris talks through the journey the company has taken over the last few years since listing until now.
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.